Missing Alzheimer's, Dementia & Autism Research Powered by MissingPatient.com

8Jan/100

George M. Brown was found

George M. Brown was found Wednesday morning in Butler, Ga., by member of the Georgia Highway Patrol.

Brown,75, who suffers from Alzheimer's, has been reported missing since Monday morning.

At the time of his disappearance, he was following his wife as they took a vehicle of theirs to a repair shop in Santa Rosa County.

According to Sgt. Scott Haines with the Santa Rosa Sheriff's Office, Brown's wife made it through the traffic light on Highway 90 in front of Home Depot, however George Brown got stopped at the light.

He never arrived at the repair shop and a Silver Alert was issued due to him disappearance and medical condition.

George Brown, who lives in Cantonment, was driving a 1994 green Ford Explorer with military decals on the front.

Late Monday night officers had an idea on his whereabouts as he used a credit card at a gas station in Quincy, Fla.

According to Haines, Brown's family went to Butler, Ga. to pick him up and he appears to be okay.

Filed under: Georgia No Comments
8Jan/100

Clarence Newbury, 83, Found Safe

A Peshtigo man reported missing Wednesday night is home safe, but only after an adventure that took him across several county lines.

Clarence Newbury, 83, suffers from Alzheimer's. He drove away from his Peshtigo home on Wednesday to go to his son's house just down the street.

After he didn't return home, his family called authorities, who found Newbury about 15 hours later, more than 70 miles away, walking along the side of Highway 41 in Grand Chute.

"It's amazing we have him home safe and sound," daughter-in-law Carol Newbury said.

There's relief today for Clarence's family and praise for the Marinette County Sheriff's Department, which took the missing person's report and alerted the media.

"Very scary. You don't know where he is, you don't know how to find him. We had all of Peshtigo people out looking for him. We went up to the cabins that we own and no one could find him," Carol said.

Then, around midnight, Marinette County deputies Chris Lesperance and Chris Tonn, on a transport to Oshkosh, spotted a disabled motorist along Highway 41 in Grand Chute.

"As we went by we said, no way, it can't be him. We turned around and came back and said, that's got to be him, just go to be. So we stopped and went to talk to him," Deputy Lesperance said.

"Sure enough, got out, and said, 'Hey, you Clarence?' He said, 'Yep.' 'You from Peshtigo?' 'Yep. My car won't start.'"

His car ran out of gas, and he seemed lost and a bit disoriented, but he was safe.

According to the Marinette County sheriff, it's a happy ending to what could have been a tragic story.

"They were diligent, they were observant, and they followed through, and I'm pleased. I'm proud of the guys and the work that they did," Sheriff Jim Kanikula said.

Good police work with a little side of luck.

"When I got that call at 12:15 last night, 15 hours that we'd been looking and praying, tears come to your eyes because you know he's safe," Carol said.

Filed under: Wisconsin No Comments
8Jan/100

Frank and Bonnie Brown were found safe

An elderly couple, both suffering from forms of dementia, have been found after they went missing from their daughter's home.

Frank and Bonnie Brown were found safe and unharmed at the home of a relative this morning. They had last been seen Thursday morning.

The couple recently moved into their daughter's home at 17816 87th Lane N. in Loxahatchee. Frank Brown III, 76, has dementia; his wife, 75, suffers from Alzheimer's.

Ricki Rubin, their daughter, told Palm Beach County Sheriff's deputies that she last saw them at breakfast, when both took their medication. She then headed for work at 8 a.m. and her husband noted they were not in the home when he came home at 5 p.m.

Filed under: Florida No Comments
8Jan/100

Frank Wlosinski, the 74 Missing

Syracuse, NY--The players who gather around the old oak table in the backroom of Steve’s Restaurant on Milton Avenue in Syracuse kept one eye on their cards and the other on the door waiting for the man they call “Shine.”

They were hoping Frank Wlosinski, the 74-year-old Camillus man missing since Saturday, would show up this afternoon to play pitch and poker.

His daughter and granddaughter stopped by the game looking for “Papa.” New York State Trooper Leon Carrodeguas checked in too.

Failing to find Wlosinski playing cards with the guys, police Friday plan to use a dog to sniff around his daughter’s home in Fairmount and his old home in Memphis.

“We’re still hoping he’ll come walking up the street,” said Chris Bilecki, of Syracuse, one of the members of the Thursday afternoon card game.

“I drive through the West End two or three times a day looking for him,” said another card player Larry Corso, who has known Wlosinski since they were little boys.

Most people know Wlosinski as “Shine”, a nickname given to him by a cousin because as a boy because he liked to sing “You Are My Sunshine.”

People who know Shine Wlosinski describe a fit former Syracuse firefighter who was a lieutenant before he retired.

He was a dapper dresser known for wearing dress shoes instead of boots in bad weather. A man who cracked wise and regularly attended Mass at the Basilica of the Sacred Heart.

They also describe a man who had begun to lose his short-term memory and sometimes disappeared for a day or two.

“We didn’t think it was too serious because he’s taking care of himself,” said his grandson Curtiss Monroe, who called Wlosinski Papa. “I think he was pretty competent.”

Papa could still drive, take care of his bills and had an active social life, Monroe said. However, he needed to be reminded about the “short- term stuff” like doctor’s appointments, the names of the great-grandchildren and cousins, he said.

Frank Geremski, of Liverpool, played cards regularly with his childhood friend, and said he encouraged him to see a doctor about his dementia.

Wlosinski disappeared for two days while visiting him in Las Vegas, Geremski said. Just a month ago, his friend disappeared for a day and a half when he returned to his old home in Memphis, he said.

Wlosinski hasn’t been seen since Saturday afternoon. He stopped in at Steve’s around 1 p.m. to watch the Syracuse University Orange men’s basketball game.

State police aren’t quite sure what happened next. A van similar to Wlosinski’s green Chrysler was involved in a minor hit and run accident that afternoon in the parking lot of Marshall’s on West Genesee Street in Fairmount.

About 4:30 p.m., Wlosinski returned to his daughter’s house at 211 Hillbrook Road. He asked his granddaughter if her parents were around, and she said no, the state trooper said.

She went upstairs, and assumed that her grandfather went to his room.

Monroe pulled up at his aunt’s house about 5 p.m. He saw Wlosinski’s van parked outside had a flat tire and a dented rim.

At first, Monroe said he thought Papa had gone somewhere to get a new tire. He looked all over house and yard for him and couldn’t find him.

State police and his old friends suspect the dementia kicked in, and that Wlosinski may have left home because he believed he was in trouble over the accident.

Wlosinski’s checkbook, driver’s license and some cash were slipped into the rectory slot at Sacred Heart, which adds to the mystery. Troopers don’t know who slipped it in the slot, Carrodeguas said.

Sunday, the family went to Sacred Heart hoping that Wlosinski would be there, Monroe said. An announcement about his disappearance was made from the pulpit, he said.

That day his grandson also went to Wlosinski’s old house on Whiting Road in Memphis. His grandfather wasn’t there, and there were no tracks in the snow to show that anyone had been around, Monroe said.

Wlosinski’s family checked every store and gas station along West Genesee Street in Camillus looking for someone who may have seen him, Monroe said. They’ve also checked along all the major routes between Fairmount and Memphis looking, he said.

They’re asking everyone to check their garages, sheds and outbuildings for Wlosinski. Anyone with tips should call the state police in Elbridge at 689-6334.

State police have checked the bus and train station, and have notified Wlosinski’s friends and relatives around the country to be on the look out for him.

“It’s frustrating for the firefighters and the retired firefighters they don’t know what to do,” said Deputy Mayor John Cowin, the city’s former fire chief. “They’d do anything, but they don’t know where to go or where to look.”

Wlosinski was “always a sunshiny guy,” Cowin said. “Hopefully he’s just lost and not out in the elements.”

Filed under: New York No Comments
8Jan/100

Anti-Alzheimer’s "cocktail" meets with disdain

A new study touting the benefits of a nutrient cocktail in preventing Alzheimer's disease is drawing fire from experts who say the results are being misrepresented.

The drink, known as Souvenaid, was developed by the French company Danone, known as Dannon in the U.S., and was based on research done at the Massachusetts Institute of Technology. It is not currently on the market.

To conduct the study, researchers in the Netherlands gave Souvenaid, which includes B vitamins, phospholipids and antioxidants, to 225 patients with Alzheimer's disease. After 12 weeks, the cocktail appeared to show a slight benefit to patients who had taken it versus those in a placebo group.

The researchers said that the "proof-of-concept study justifies further clinical trials." Indeed, several such studies are currently under way.

However, numbers in the study indicated a reasonably high probability that some of the results could be due to chance, and some of the drink's apparent benefits seemed to disappear quickly, critics say.

"I see little evidence to support the use of this beverage to improve memory in [Alzheimer's disease patients]," said Dr. Paul Aisen, a noted Alzheimer's disease expert and professor at the University of California, San Diego. "It was a small study of treatment-naïve [Alzheimer's] patients lasting only 12 weeks." By 24 weeks, the memory differences seen after 12 weeks had disappeared.

The study was published in the most recent issue of the journal Alzheimer's & Dementia.

Experts also pointed out that some of the memory tests failed to show any improvement in people using the cocktail.

"This is a study which I would look at as negative," said Dr. Constantine Lyketsos, director of the Neuropsychiatry Service at Johns Hopkins Medical Institution. "The major outcome measures showed no effect at any time point."

Dr. Richard Besser, senior medical editor for ABC News, noted some troubling aspects of the study that related to its potential marketing, including conflicts of interest by the authors.

"They hold the patent on the nutritional cocktail and some serve on the advisory board for Dannon. The study was funded by Dannon," he said.

Other experts, too, were critical of the study.

"While everyone would clearly like to have some safe and easy to take method to stave off Alzheimer's disease, there are several features of this study that should raise concerns," said Dr. Clifford Saper, chairman of the Department of Neurology at Beth Israel Deaconess Medical Center in Boston. "They would include the involvement of the commercial sponsors at every level of this study, including writing the first draft of the paper; and the relatively low level of improvement on a single test out of a large battery of examinations."

Study co-author Dr. Richard Wurtman of MIT in Boston said he didn't think the sponsor was overly involved, but added he -- as a basic scientist -- was himself not deeply involved in the clinical aspect of the trial.

And in an e-mail, study author Dr. Philip Scheltens of VU University Medical Center in Amsterdam, the Netherlands, said the trial is "a proof of concept that urges further study, which we are doing."

He added that the study was indeed analyzed by the sponsor, but also by an external statistician, who is also a co-author of the paper.

There has been a strong desire for an effective Alzheimer's drug, given the number of people who suffer from the ailment -- a number that will grow if demographic trends continue.

"There is a tremendous unmet need since existing drugs offer only symptomatic benefits," said Dr. Murali Doraiswamy, chief of the division of biological psychiatry at Duke Medical Center.

However, he cautioned, "At this point I would not recommend that anyone get excited by this or start medicating themselves with these ingredients till we have results from more definitive studies. At best, this study offers some grounds for further testing."

He noted that while the ingredients had been suspected of having brain benefits in the past, "none of the ingredients have been shown to work in prior large scale trials of people with Alzheimer's."

Also, Doraiswamy said, a trial would need to be significantly longer for a product to be seriously considered.

"The typical standard for a definitive FDA trial is six-month duration," Doraiswamy said.
- ABC News

 

8Jan/100

Anti-Alzheimer’s "cocktail" meets with disdain

A new study touting the benefits of a nutrient cocktail in preventing Alzheimer's disease is drawing fire from experts who say the results are being misrepresented.

The drink, known as Souvenaid, was developed by the French company Danone, known as Dannon in the U.S., and was based on research done at the Massachusetts Institute of Technology. It is not currently on the market.

To conduct the study, researchers in the Netherlands gave Souvenaid, which includes B vitamins, phospholipids and antioxidants, to 225 patients with Alzheimer's disease. After 12 weeks, the cocktail appeared to show a slight benefit to patients who had taken it versus those in a placebo group.

The researchers said that the "proof-of-concept study justifies further clinical trials." Indeed, several such studies are currently under way.

However, numbers in the study indicated a reasonably high probability that some of the results could be due to chance, and some of the drink's apparent benefits seemed to disappear quickly, critics say.

"I see little evidence to support the use of this beverage to improve memory in [Alzheimer's disease patients]," said Dr. Paul Aisen, a noted Alzheimer's disease expert and professor at the University of California, San Diego. "It was a small study of treatment-naïve [Alzheimer's] patients lasting only 12 weeks." By 24 weeks, the memory differences seen after 12 weeks had disappeared.

The study was published in the most recent issue of the journal Alzheimer's & Dementia.

Experts also pointed out that some of the memory tests failed to show any improvement in people using the cocktail.

"This is a study which I would look at as negative," said Dr. Constantine Lyketsos, director of the Neuropsychiatry Service at Johns Hopkins Medical Institution. "The major outcome measures showed no effect at any time point."

Dr. Richard Besser, senior medical editor for ABC News, noted some troubling aspects of the study that related to its potential marketing, including conflicts of interest by the authors.

"They hold the patent on the nutritional cocktail and some serve on the advisory board for Dannon. The study was funded by Dannon," he said.

Other experts, too, were critical of the study.

"While everyone would clearly like to have some safe and easy to take method to stave off Alzheimer's disease, there are several features of this study that should raise concerns," said Dr. Clifford Saper, chairman of the Department of Neurology at Beth Israel Deaconess Medical Center in Boston. "They would include the involvement of the commercial sponsors at every level of this study, including writing the first draft of the paper; and the relatively low level of improvement on a single test out of a large battery of examinations."

Study co-author Dr. Richard Wurtman of MIT in Boston said he didn't think the sponsor was overly involved, but added he -- as a basic scientist -- was himself not deeply involved in the clinical aspect of the trial.

And in an e-mail, study author Dr. Philip Scheltens of VU University Medical Center in Amsterdam, the Netherlands, said the trial is "a proof of concept that urges further study, which we are doing."

He added that the study was indeed analyzed by the sponsor, but also by an external statistician, who is also a co-author of the paper.

There has been a strong desire for an effective Alzheimer's drug, given the number of people who suffer from the ailment -- a number that will grow if demographic trends continue.

"There is a tremendous unmet need since existing drugs offer only symptomatic benefits," said Dr. Murali Doraiswamy, chief of the division of biological psychiatry at Duke Medical Center.

However, he cautioned, "At this point I would not recommend that anyone get excited by this or start medicating themselves with these ingredients till we have results from more definitive studies. At best, this study offers some grounds for further testing."

He noted that while the ingredients had been suspected of having brain benefits in the past, "none of the ingredients have been shown to work in prior large scale trials of people with Alzheimer's."

Also, Doraiswamy said, a trial would need to be significantly longer for a product to be seriously considered.

"The typical standard for a definitive FDA trial is six-month duration," Doraiswamy said.
- ABC News